Evidence map›Paper›PMID 36031617›Full record

ArticleBMC infectious diseases2022

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana.

Lynnette Bhebhe, Sikhulile Moyo, Simani Gaseitsiwe, Molly Pretorius-Holme, Etienne K Yankinda, Kutlo Manyake, Coulson Kgathi, Mompati Mmalane, Refeletswe Lebelonyane, Tendani Gaolathe and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01965470 (Botswana Combination Prevention Project), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01965470 phase4completednot on this map

Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana

TypeinterventionalSponsorCenters for Disease Control and PreventionRan2013 to 2018ConditionsHIVArmsCombination Prevention, Enhanced Care
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Lynnette BhebheBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Sikhulile MoyoBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Simani GaseitsiweBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Molly Pretorius-HolmeDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Etienne K YankindaBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Kutlo ManyakeBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Coulson KgathiBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Mompati MmalaneBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Refeletswe LebelonyaneMinistry of Health and Wellness, Gaborone, Botswana.
Tendani GaolatheBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Pamela BachanasCenters for Disease Control and Prevention, Atlanta, GA, USA.
Faith UsseryCenters for Disease Control and Prevention, Atlanta, GA, USA.
Mpho LetebeleCenters for Disease Control and Prevention, Gaborone, Botswana.
Joseph MakhemaBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Kathleen E WirthCenters for Disease Control and Prevention, Atlanta, GA, USA.
Shahin LockmanBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Max EssexDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Vlad NovitskyDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Manon Ragonnet-CroninMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. manonragonnet@uchicago.edu.
Botswana Harvard AIDS Institute Partnership · BWHarvard University · USCenters for Disease Control and Prevention · USImperial College London · GBMinistry of Health · BW

Funding

H3ABioNet: a sustainable African Bioinformatics Network for H3AfricaU41HG006941 · NHGRI · UNIVERSITY OF CAPE TOWN · PI MULDER, NICOLA · 2012 to 2017
$14.8M
Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
Mentoring in Patient-Oriented HIV Research in the Era of Universal ARTK24AI131928 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAHIN LOCKMAN · 2017 to 2026
$1.9M
Bill and Melinda Gates Foundation OPP1084362Bill and Melinda Gates Foundation OPP1175094CGH CDC HHS U01 GH000447CGH CDC HHS U2G GH000073CGH CDC HHS U2G GH000419CGH CDC HHS U2G GH001911DELTAS Africa Initiative DEL-15-006FIC NIH HHS D43 TW010543FIC NIH HHS D43TW010543Foundation for the National Institutes of Health K24AI131928Medical Research Council MR/R015600/1NHGRI NIH HHS U41 HG006941NHGRI NIH HHS U41HG006941NIAID NIH HHS K24 AI131928U.S. President's Emergency Plan for AIDS Relief U2G GH002027Wellcome TrustWellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

backgroundHIV-1 is endemic in Botswana. The country's primary challenge is identifying people living with HIV who are unaware of their status. We evaluated factors associated with undiagnosed HIV infection using HIV-1 phylogenetic, behavioural, and demographic data.

methodsAs part of the Botswana Combination Prevention Project, 20% of households in 30 villages were tested for HIV and followed from 2013 to 2018. A total of 12,610 participants were enrolled, 3596 tested HIV-positive at enrolment, and 147 participants acquired HIV during the trial. Extensive socio-demographic and behavioural data were collected from participants and next-generation sequences were generated for HIV-positive cases. We compared three groups of participants: (1) those previously known to be HIV-positive at enrolment (n = 2995); (2) those newly diagnosed at enrolment (n = 601) and (3) those who tested HIV-negative at enrolment but tested HIV-positive during follow-up (n = 147). We searched for differences in demographic and behavioural factors between known and newly diagnosed group using logistic regression. We also compared the topology of each group in HIV-1 phylogenies and used a genetic diversity-based algorithm to classify infections as recent (< 1 year) or chronic (≥ 1 year).

resultsBeing male (aOR = 2.23) and younger than 35 years old (aOR = 8.08) was associated with undiagnosed HIV infection (p < 0.001), as was inconsistent condom use (aOR = 1.76). Women were more likely to have undiagnosed infections if they were married, educated, and tested frequently. For men, being divorced increased their risk. The genetic diversity-based algorithm classified most incident infections as recent (75.0%), but almost none of known infections (2.0%). The estimated proportion of recent infections among new diagnoses was 37.0% (p < 0.001).

conclusionOur results indicate that those with undiagnosed infections are likely to be young men and women who do not use condoms consistently. Among women, several factors were predictive: being married, educated, and testing frequently increased risk. Men at risk were more difficult to delineate. A sizeable proportion of undiagnosed infections were recent based on a genetic diversity-based classifier. In the era of "test and treat all", pre-exposure prophylaxis may be prioritized towards individuals who self-identify or who can be identified using these predictors in order to halt onward transmission in time.

Indexed as

HIV-1HIV InfectionsAdultBotswanaCondomsFemaleHomosexuality, MaleHumansMalePhylogenyHIVPhylogeneticsRecent HIV infectionUndiagnosed infection

Identifiers

PMID36031617
PMCPMC9420270
OpenAlexW4293373659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.